207 related articles for article (PubMed ID: 32391547)
1. Lowe syndrome patient cells display mTOR- and RhoGTPase-dependent phenotypes alleviated by rapamycin and statins.
Madhivanan K; Ramadesikan S; Hsieh WC; Aguilar MC; Hanna CB; Bacallao RL; Aguilar RC
Hum Mol Genet; 2020 Jun; 29(10):1700-1715. PubMed ID: 32391547
[TBL] [Abstract][Full Text] [Related]
2. The Lowe syndrome protein OCRL1 is involved in primary cilia assembly.
Coon BG; Hernandez V; Madhivanan K; Mukherjee D; Hanna CB; Barinaga-Rementeria Ramirez I; Lowe M; Beales PL; Aguilar RC
Hum Mol Genet; 2012 Apr; 21(8):1835-47. PubMed ID: 22228094
[TBL] [Abstract][Full Text] [Related]
3. Role of Ocrl1 in primary cilia assembly.
Madhivanan K; Ramadesikan S; Aguilar RC
Int Rev Cell Mol Biol; 2015; 317():331-47. PubMed ID: 26008789
[TBL] [Abstract][Full Text] [Related]
4. Lowe syndrome patient fibroblasts display Ocrl1-specific cell migration defects that cannot be rescued by the homologous Inpp5b phosphatase.
Coon BG; Mukherjee D; Hanna CB; Riese DJ; Lowe M; Aguilar RC
Hum Mol Genet; 2009 Dec; 18(23):4478-91. PubMed ID: 19700499
[TBL] [Abstract][Full Text] [Related]
5. OCRL-mutated fibroblasts from patients with Dent-2 disease exhibit INPP5B-independent phenotypic variability relatively to Lowe syndrome cells.
Montjean R; Aoidi R; Desbois P; Rucci J; Trichet M; Salomon R; Rendu J; Fauré J; Lunardi J; Gacon G; Billuart P; Dorseuil O
Hum Mol Genet; 2015 Feb; 24(4):994-1006. PubMed ID: 25305077
[TBL] [Abstract][Full Text] [Related]
6. Structure and function of the Lowe syndrome protein OCRL1.
Lowe M
Traffic; 2005 Sep; 6(9):711-9. PubMed ID: 16101675
[TBL] [Abstract][Full Text] [Related]
7. The cellular and physiological functions of the Lowe syndrome protein OCRL1.
Mehta ZB; Pietka G; Lowe M
Traffic; 2014 May; 15(5):471-87. PubMed ID: 24499450
[TBL] [Abstract][Full Text] [Related]
8. Genotype & phenotype in Lowe Syndrome: specific OCRL1 patient mutations differentially impact cellular phenotypes.
Ramadesikan S; Skiba L; Lee J; Madhivanan K; Sarkar D; De La Fuente A; Hanna CB; Terashi G; Hazbun T; Kihara D; Aguilar RC
Hum Mol Genet; 2021 Apr; 30(3-4):198-212. PubMed ID: 33517444
[TBL] [Abstract][Full Text] [Related]
9. A novel OCRL1 mutation in a patient with the mild phenotype of Lowe syndrome.
Sugimoto K; Nishi H; Miyazawa T; Fujita S; Okada M; Takemura T
Tohoku J Exp Med; 2014 Mar; 232(3):163-6. PubMed ID: 24614960
[TBL] [Abstract][Full Text] [Related]
10. Lowe syndrome - Case report with a novel mutation in the oculocerebrorenal gene.
Sethi S; Sethi N; Mehta S; Kaur S; Makkar V; Sohal PM
Saudi J Kidney Dis Transpl; 2020; 31(1):285-288. PubMed ID: 32129227
[TBL] [Abstract][Full Text] [Related]
11. Kidney-differentiated cells derived from Lowe Syndrome patient's iPSCs show ciliogenesis defects and Six2 retention at the Golgi complex.
Hsieh WC; Ramadesikan S; Fekete D; Aguilar RC
PLoS One; 2018; 13(2):e0192635. PubMed ID: 29444177
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity in Lowe Syndrome: Mutations Affecting the Phosphatase Domain of OCRL1 Differ in Impact on Enzymatic Activity and Severity of Cellular Phenotypes.
Lee JJ; Ramadesikan S; Black AF; Christoffer C; Pacheco AFP; Subramanian S; Hanna CB; Barth G; Stauffacher CV; Kihara D; Aguilar RC
Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189363
[TBL] [Abstract][Full Text] [Related]
13. Ocular Pathology of Oculocerebrorenal Syndrome of Lowe: Novel Mutations and Genotype-Phenotype Analysis.
Song E; Luo N; Alvarado JA; Lim M; Walnuss C; Neely D; Spandau D; Ghaffarieh A; Sun Y
Sci Rep; 2017 May; 7(1):1442. PubMed ID: 28473699
[TBL] [Abstract][Full Text] [Related]
14. Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice.
Jänne PA; Suchy SF; Bernard D; MacDonald M; Crawley J; Grinberg A; Wynshaw-Boris A; Westphal H; Nussbaum RL
J Clin Invest; 1998 May; 101(10):2042-53. PubMed ID: 9593760
[TBL] [Abstract][Full Text] [Related]
15. Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome.
Egot M; Lasne D; Poirault-Chassac S; Mirault T; Pidard D; Dreano E; Elie C; Gandrille S; Marchelli A; Baruch D; Rendu J; Fauré J; Flaujac C; Gratacap MP; Sié P; Gaussem P; Salomon R; Baujat G; Bachelot-Loza C
Br J Haematol; 2021 Mar; 192(5):909-921. PubMed ID: 33528045
[TBL] [Abstract][Full Text] [Related]
16. Lowe syndrome protein OCRL1 interacts with Rac GTPase in the trans-Golgi network.
Faucherre A; Desbois P; Satre V; Lunardi J; Dorseuil O; Gacon G
Hum Mol Genet; 2003 Oct; 12(19):2449-56. PubMed ID: 12915445
[TBL] [Abstract][Full Text] [Related]
17. Lowe syndrome: Between primary cilia assembly and Rac1-mediated membrane remodeling.
Madhivanan K; Mukherjee D; Aguilar RC
Commun Integr Biol; 2012 Nov; 5(6):641-4. PubMed ID: 23739214
[TBL] [Abstract][Full Text] [Related]
18. The effect of missense mutations in the RhoGAP-homology domain on ocrl1 function.
Lichter-Konecki U; Farber LW; Cronin JS; Suchy SF; Nussbaum RL
Mol Genet Metab; 2006; 89(1-2):121-8. PubMed ID: 16777452
[TBL] [Abstract][Full Text] [Related]
19. The deficiency of PIP2 5-phosphatase in Lowe syndrome affects actin polymerization.
Suchy SF; Nussbaum RL
Am J Hum Genet; 2002 Dec; 71(6):1420-7. PubMed ID: 12428211
[TBL] [Abstract][Full Text] [Related]
20. From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes.
Hichri H; Rendu J; Monnier N; Coutton C; Dorseuil O; Poussou RV; Baujat G; Blanchard A; Nobili F; Ranchin B; Remesy M; Salomon R; Satre V; Lunardi J
Hum Mutat; 2011 Apr; 32(4):379-88. PubMed ID: 21031565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
